Impact of COVID-19 on health-related quality of life for people with inflammatory arthritis

People with autoimmune conditions, such as inflammatory arthritis, have a potentially increased risk of more serious COVID-19 infection. Some people with these conditions, who are taking certain immunosuppressive medication, have been advised to ‘shield’ and self-isolate for a period of up to 12-weeks. In addition, people with these conditions are at an increased risk of other consequences for their quality of life, for example due to reduced access to healthcare, and from reduced ability to exercise and obtain social support. Together these may have an impact on the health and well-being of many people with inflammatory arthritis now and in the future.

Researchers at King’s College London (Principle investigator Dr Sam Norton) are conducting this online survey to try and understand the impacts of COVID-19, and related social distancing measures, on people with various types of inflammatory arthritis who would typically be prescribed immunosuppressive medications, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and lupus. Specifically, we want to understand whether healthcare access and symptom self-manage activities have been affected, and the wider mental and physical health impacts.

This online survey should take you around 20-30 minutes to complete. Your participation in this research is voluntary and you have the right to withdraw at any point during the study.

The survey will be repeated on two further occasions, once in the summer of 2020 and once in the summer of 2021, to understand the longer term-impacts of COVID-19.

Click here to access the survey